TPG Group Holdings (SBS) Advisors, Inc.
Institutional investor · Portfolio as of Q4 2014No 13F holdings reported for quarters after Q3 2021. Holdings now reported by TPG GP A.
Top Holdings38 positions
1793264 | 196.1M | $4.9B | 30.2% | — | — | 1 qtr | First report 0 |
12571 | 159.7M | $4.1B | 25.0% | — | — | 1 qtr | First report 0 |
Sabre Corp | 151.2M | $3.1B | 18.7% | $17.75 | 0.00% | 1 qtr | First report 0 |
Surgical Care Affiliates, Inc. | 23.9M | $805.6M | 4.9% | — | — | 1 qtr | First report 0 |
Norwegian Cruise Line Holdings | 16.1M | $751.9M | 4.6% | $46.86 | 0.00% | 1 qtr | First report 0 |
| 11.2M | $659.8M | 4.0% | — | — | 1 qtr | First report 0 | |
LPL Financial Holdings Inc | 12.9M | $574.1M | 3.5% | $38.17 | 0.00% | 1 qtr | First report 0 |
| 23.7M | $435.2M | 2.7% | — | — | 1 qtr | First report 0 | |
| 8.7M | $166.5M | 1.0% | — | — | 1 qtr | First report 0 | |
AV Homes Inc. | 9.2M | $134.3M | 0.8% | — | — | 1 qtr | First report 0 |
Ultragenyx Pharmaceutical Inc | 2.1M | $92M | 0.6% | $44.04 | 0.00% | 1 qtr | First report 0 |
ALDER BIOPHARMACEUTICALS INC | 2.5M | $72.4M | 0.4% | — | — | 1 qtr | First report 0 |
OTONOMY INC | 2.2M | $72M | 0.4% | — | — | 1 qtr | First report 0 |
AERIE PHARMACEUTICALS INC | 2.1M | $60.9M | 0.4% | — | — | 1 qtr | First report 0 |
TPG SPECIALTY LENDING INC | 3.2M | $54.4M | 0.3% | $5.45 | 0.00% | 1 qtr | First report 0 |
VERACYTE INC | 3.6M | $34.3M | 0.2% | $9.52 | 0.00% | 1 qtr | First report 0 |
Tandem Diabetes Care, Inc. | 2.5M | $31.7M | 0.2% | $122.80 | 0.00% | 1 qtr | First report 0 |
FIVE PRIME THERAPEUTICS INC | 1.1M | $28.5M | 0.2% | — | — | 1 qtr | First report 0 |
INTERACTIVE BROKERS GROUP INC CL-A | 958,702 | $28M | 0.2% | $6.76 | 0.00% | 1 qtr | First report 0 |
Verint Systems Inc | 477,084 | $27.8M | 0.2% | — | — | 1 qtr | First report 0 |
TPG Group Holdings (SBS) Advisors, Inc. reported holdings worth $16.4B across 38 positions as of Q4 2014. Top holdings: FSL (30.2%), IMS (25.0%), SABR (18.7%). Fund DNA: Balanced Allocator.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR